IBA Proton Therapy
IBA Proton Therapy is a Belgian division of IBA (Ion Beam Applications) that designs, manufactures, and services ProteusONE and ProteusPLUS proton beam therapy systems, plus innovation modules, for hospitals and cancer centers worldwide, supported by recurring maintenance and consulting contracts.
- Company typePrivate
- Founded1986
- HeadquartersLouvain-la-neuve, Belgium
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What IBA Proton Therapy does
IBA Proton Therapy is the proton therapy division of Belgian-headquartered IBA (Ion Beam Applications), established in 1986 and based in Louvain-la-Neuve. The business designs, manufactures, and services proton beam therapy systems for cancer treatment, using cyclotron accelerators to generate proton beams that can be precisely targeted to tumor depths to minimize radiation exposure to surrounding healthy tissue. Its core platform is the Proteus family, comprising ProteusONE (a compact single-room system designed for accessibility at smaller oncology centers) and ProteusPLUS (a full-scale multi-room system for leading cancer centers), both delivering image-guided, intensity-modulated proton beam therapy. The portfolio is augmented by innovation modules including DynamicARC (proton arc therapy), ConformalFLASH (ultra-high dose rate FLASH therapy), and Motion Management for tumor-motion compensation, though the latter two remain pending regulatory clearance.
The company sells high-value capital medical equipment directly to hospitals and cancer treatment centers through an enterprise field-sales motion, with each engagement spanning consultation, custom configuration, building consulting, installation, commissioning, training, and multi-year maintenance contracts. Revenue therefore combines lumpy hardware sales, professional services, and a more predictable recurring service layer on the installed base; pricing is quote-based and not publicly disclosed. Customers include globally recognized cancer centers such as Mass General, University of Pennsylvania, Northwestern Medicine, Institut Curie, Apollo Proton Cancer Centre, and Miami Cancer Institute, with 60+ centers worldwide using IBA equipment and 140,000+ patients treated on the platform.
IBA Proton Therapy has built a community franchise around its installed base, featuring named clinical KOLs and a center locator, marketed through the IBA Community program and industry events such as ASTRO. The company describes itself as the first global proton therapy provider and the most advanced in the field, drawing on five decades of accumulated medical technology knowledge to support both new system sales and ongoing protocol development across its partner network.
IBA Proton Therapy firmographics
Firmographics- Name
- IBA Proton Therapy
- Legal name
- IBA Proton Therapy
- Website
- https://iba-protontherapy.com
- Company type
- Private
- Founded year
- 1986
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- IBA Proton Therapy is a Belgian division of IBA (Ion Beam Applications) that designs, manufactures, and services ProteusONE and ProteusPLUS proton beam therapy systems, plus innovation modules, for hospitals and cancer centers worldwide, supported by recurring maintenance and consulting contracts.
- Ownership category
- akta.pro rank
IBA Proton Therapy industry classification
Industry- Product category
- Radiation Oncology Equipment
- NAICS
- Irradiation Apparatus Manufacturing (334517)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Radiation Oncology (HLAKAFAC)
Keywords
Where IBA Proton Therapy is headquartered
LocationHeadquarters
- HQ city
- Louvain-la-neuve
- HQ country
- Belgium
- HQ region
- Europe
Markets served
IBA Proton Therapy business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- Proton Therapy Systems Sales: Sale of proton therapy equipment including ProteusONE and ProteusPLUS systems. High-value capital equipment sales to hospitals and cancer centers with custom configuration and installation.
- Professional Services: Comprehensive services including building consulting, training, commissioning, maintenance, and upgrades for proton therapy centers.
- Ongoing Maintenance and Support: Recurring maintenance, technical support, and upgrade services for installed proton therapy systems.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom enterprise pricing based on system configuration, facility requirements, and service needs |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
IBA Proton Therapy product offering
Product offeringCore offering
IBA Proton Therapy manufactures and sells proton therapy systems (ProteusONE and ProteusPLUS) that use cyclotron accelerators to generate and deliver proton beams for precise, image-guided, intensity-modulated cancer treatment. The company also provides innovation modules (DynamicARC, ConformalFLASH, Motion Management) and related services such as building consulting, training, commissioning, and ongoing maintenance for proton therapy centers worldwide.
Product overview
IBA Proton Therapy offers a platform-based product portfolio centered on its Proteus proton therapy systems. ProteusONE is a compact system designed for accessibility, while ProteusPLUS provides a larger-scale versatile solution. Both core products deliver precise, image-guided, intensity-modulated proton beam therapy. The portfolio is enhanced by innovation modules including DynamicARC (proton arc therapy), ConformalFLASH (FLASH therapy), and Motion Management. The company also provides comprehensive services including building consulting, training, commissioning, and maintenance. With over 60 proton therapy centers worldwide and more than 140,000 patients treated on IBA equipment, the company serves leading cancer centers globally.
Differentiator
Problem solved
Functional benefit
Brands
- ProteusONE: A versatile proton therapy system designed for clinical excellence and advanced patient care, featuring precise, image-guided, intensity-modulated beam technology for leading cancer centers.
- ProteusPLUS
- DynamicARC
- ConformalFLASH
Products and services
- ProteusONE Compact, versatile proton therapy system designed for clinical excellence and advanced patient care, delivering precise, image-guided, and intensity-modulated proton beam therapy to treat a broad range of tumors safely and effectively. Targeted at oncology centers seeking accessible proton therapy capabilities.
- ProteusPLUS Versatile, full-scale proton therapy system designed for leading cancer centers, enabling treatment of a broader range of tumors more safely and effectively with cutting-edge features tailored to research and clinical needs.
- Building & Consulting Services Consulting services supporting the planning, construction, and commissioning of proton therapy centers, including business planning and facility setup. Targeted at hospitals and cancer centers establishing proton therapy capabilities.
- Training Services Training programs for healthcare professionals and technical staff responsible for operating proton therapy equipment and managing treatment facilities.
Quantifiable outcome
- Over 140,000 cancer patients treated on IBA equipment demonstrating proven clinical track record
Companies that use IBA Proton Therapy
Customer profileNamed customers13 records
Segments1 record
Ideal customer profiles1 record
IBA Proton Therapy technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
IBA Proton Therapy partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- IBA Community (Global Partner Network)coreIBA forms the most knowledgeable proton therapy community by working hand in hand with customers and partners. The community includes over 60 proton therapy centers worldwide collaborating to eliminate cancer through shared expertise, best practices, and continuous innovation in proton therapy technology and treatment protocols.
Scale indicators3 records
Recent moves5 records
Expansion highlights6 records
IBA Proton Therapy competitors and assessment
Company assessmentDirect peers
- Elekta: Major radiation therapy and radiosurgery vendor with linear accelerators and emerging particle therapy efforts. Competes with IBA for hospital capital budgets and ongoing service contracts in oncology centers.
- Mevion Medical Systems: U.S.-based compact proton therapy vendor using single-room designs broadly comparable to IBA's ProteusONE. Directly targets the same mid-size oncology center customer with a smaller-footprint alternative.
- Varian Medical Systems (Siemens Healthineers): Largest radiation therapy vendor globally, offering proton therapy (ProBeam) alongside dominant photon IMRT/VMAT systems. Directly competes with IBA in proton sales and increasingly bundles photon + proton offerings to the same hospital customers.
- Sumitomo Heavy Industries: Japanese manufacturer of proton therapy systems with multi-room installations, primarily in Asia. Directly competes with IBA in Asia-Pacific tenders for proton therapy centers.
- Hitachi (particle therapy): Operates a proton and heavy-ion therapy business that has installed multi-room proton systems globally. Directly competes with IBA's ProteusPLUS in flagship academic and government hospital tenders.
Emerging players
- TAE Life Sciences: Developer of accelerator-based boron neutron capture therapy (BNCT) systems. Competes for the same next-generation particle therapy narrative and hospital partnerships that IBA is pursuing with FLASH and arc therapy.
- RefleXion Medical: Biology-guided radiotherapy (BgRT) company whose systems integrate PET signals with linear accelerators to target tumors. Represents an emerging photon-based alternative to proton therapy for some indications.
- ViewRay: Developer of MR-guided radiation therapy systems (MRIdian), positioned as an alternative advanced radiotherapy modality. Competes for the same hospital advanced-radiotherapy capital dollar as IBA's proton systems.
Broad incumbents
- GE Healthcare: Diversified imaging and oncology vendor that participates in the broader cancer care ecosystem. Competes indirectly via imaging, simulation, and treatment-planning tools that bundle with or substitute for proton-only vendors.
- Philips (radiation oncology): Broader healthcare imaging and therapy vendor with oncology software and treatment-planning offerings. Indirectly competes by providing complementary/competing technology stacks that hospitals consider alongside a proton therapy purchase.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat7 records
Key risks6 records
Key highlights6 records
Customer concentration
IBA Proton Therapy social profiles
Digital presenceIBA Proton Therapy financial estimates
Financial estimateRevenue estimate
Valuation estimate
IBA Proton Therapy leadership team
Management profileNumber of profiles
IBA Proton Therapy funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
IBA Proton Therapy M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about IBA Proton Therapy
What does IBA Proton Therapy do?
IBA Proton Therapy manufactures and sells proton therapy systems (ProteusONE and ProteusPLUS) that use cyclotron accelerators to generate and deliver proton beams for precise, image-guided, intensity-modulated cancer treatment. The company also provides innovation modules (DynamicARC, ConformalFLASH, Motion Management) and related services such as building consulting, training, commissioning, and ongoing maintenance for proton therapy centers worldwide.
Is IBA Proton Therapy a public or private company?
IBA Proton Therapy is a private company. It is classified as public and is currently operating.
When was IBA Proton Therapy founded?
IBA Proton Therapy was founded in 1986. It employs 101 to 250 people.
Where is IBA Proton Therapy based?
IBA Proton Therapy is headquartered in Louvain-la-neuve, Belgium, in the Europe region.
How does IBA Proton Therapy make money?
Three revenue lines are on record. Proton Therapy Systems Sales are the primary driver. The others are professional Services and ongoing Maintenance and Support.
Who are IBA Proton Therapy's main competitors?
Direct peers on record are Elekta, Mevion Medical Systems, Varian Medical Systems (Siemens Healthineers), Sumitomo Heavy Industries and Hitachi (particle therapy). Emerging players are TAE Life Sciences, RefleXion Medical and ViewRay. Broad incumbents are GE Healthcare and Philips (radiation oncology).
Does IBA Proton Therapy have an API?
No public API is recorded for IBA Proton Therapy.
What industry is IBA Proton Therapy in?
IBA Proton Therapy's product category is Radiation Oncology Equipment. Its primary akta.pro industry code is HLAKAFAC, Radiation Oncology. Its NAICS code is 334517 and its SIC code is 3841.